Share

    


Home / Search Results

Search Results

You searched for:

State legislation across the U.S. is tackling health insurance coverage for comprehensive biomarker testing. Learn more about what's going on where you live and across the nation.
Teri Bedard, RT(R)(T), CPC, shares her highlights of the calendar year 2023 MPFS proposed rule and its potential impact on oncology/hematology.
ACCC Director Cancer Care Delivery and Health Policy Matt Devino, MPH, lays out the four key differences between the OCM and EOM that interested applicants need to consider.
As the United States healthcare system moves to value-based and bundled payments under alternative payment models, it is now more important than ever for cancer programs and practices to quantitatively and qualitatively measure to show the value that supportive cancer care services bring to patients.